Transcription of Cellular Therapies – Program Chairs: Baculovirus ...
{{id}} {{{paragraph}}}
Example: bachelor of science
Cellular Therapies – Program Chairs: Baculovirus ...
Viral Vectors & Vaccines Program Chairs: Cellular Therapies Program Chairs: Baculovirus Expression Technology Program Chairs: Otto-Wilhelm Merten, PhD G n thon Martin A. Giedlin, PhD Novartis Pharmaceuticals Corporation Manuel Carrondo, PhD Instituto de Biologia Amine A. Kamen, PhD McGill University Gary K. Lee, PhD Sangamo BioSciences, Inc. Experimental e Tecnol gica (iBET). Clifton E. McPherson, PhD Protein Sciences Corporation, A Sanofi Company SUNDAY MARCH 4, 2018. 3:00 pm 7:00 pm Welcome Reception and Registration in the Granby Ballroom Foyer, Third Floor MONDAY MARCH 5, 2018. 7:00 am 8:00 am Registration and Breakfast in the Granby Ballroom Foyer, Third Floor 8:00 am 8:30 am Meeting Overview in Momentum, Third Floor Viral Vectors & Vaccines Cellular Therapies Baculovirus Expression Technology Momentum, Third Floor Fusion, Third Floor Energy, Third Floor View Speaker Abstracts & Bios View Speaker Abstracts & Bios View Speaker Abstracts & Bios 8
2 ISBioTech 8th Spring Meeting (continued): TUESDAY MARCH 6, 2018• Viral Vectors & Vaccines Momentum, Third Floor Cellular Therapies Fusion, Third Floor
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Clinical Pharmacokinetic Studies of Pharmaceuticals, Pharmaceuticals and Medical Devices Safety Information, Celgene, Immune Globulin Intravenous Human, Antihemophilic Factor, Recombinant only, Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer, Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer Health